Parenteral fish oil-associated burr cell anemia.
We report the development of burr cell anemia in an infant with short bowel syndrome who received parenteral fish oil (Omegaven, Fresenius-Kabi, Graz, Austria) after development of total parenteral nutrition-associated liver disease. Parenteral fish oil was discontinued, and the burr cell anemia disappeared, suggesting that parenteral fish oil might be associated with hemolytic anemia.
Mallah
Husam S
HS
Division of Pediatric Gastroenterology and Nutrition, Gastroenterology and Nutrition Section, University of Rochester, 601 Elmwood Ave., Box 667 Rochester, NY 14642, USA. husam_mallah@urmc.rochester.edu
Brown
Marilyn R
MR
Rossi
Thomas M
TM
Block
Robert C
RC
D000740:Anemia / Q000209:etiology*; D002779:Cholestasis / Q000209:etiology / Q000628:therapy; D004913:Erythrocytes, Abnormal; D005260:Female; D005395:Fish Oils / Q000008:administration & dosage / Q000009:adverse effects*; D020139:Gastroschisis / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D007409:Intestinal Atresia / Q000628:therapy; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*
D005395:Fish Oils